![Eric Nils Gunnar Wahlberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Nils Gunnar Wahlberg
Corporate Officer/Principal chez University of Linköping
Postes actifs de Eric Nils Gunnar Wahlberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Linköping
![]() University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
Historique de carrière de Eric Nils Gunnar Wahlberg
Anciens postes connus de Eric Nils Gunnar Wahlberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
AstraZeneca UK Ltd.
![]() AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
NOVARTIS AG | Corporate Officer/Principal | - | - |
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Suède | 3 |
Royaume-Uni | 2 |
Suisse | 2 |
Opérationnelle
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NOVARTIS AG | Health Technology |
Entreprise privées | 2 |
---|---|
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Health Technology |
AstraZeneca UK Ltd.
![]() AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom. | Commercial Services |
- Bourse
- Insiders
- Eric Nils Gunnar Wahlberg
- Expérience